MedPath

safety testing of Investigational products by assessing the irritation after patch application onhealthy human volunteers.

Not Applicable
Completed
Registration Number
CTRI/2018/01/011525
Lead Sponsor
ITC LIMITED ITC Life Sciences and Technology Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarâ?¦.)

Subjects representing varied skin types (ideally equal representation of all 4 skin types â?? Oily, Normal, Dry and combination) Subjects willing to come for regular follow up and ready to follow instructions during the study period

Exclusion Criteria

For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing

(whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the dermatological safety of <br/ ><br>investigational products by primary irritation <br/ ><br>patch test on healthy human volunteers of varied <br/ ><br>skin types <br/ ><br>Timepoint: T0, T1, T2 AND T8
Secondary Outcome Measures
NameTimeMethod
not applicableTimepoint: not applicable
© Copyright 2025. All Rights Reserved by MedPath